Medilente Pharma Private Limited

Medilente Pharma Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24232CH2013PTC034546 Incorporated 12 June 2013 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹3.24 Cr
▲ 11% YoY
Net profit · FY 2024
₹5.99 Lakh
Net margin 1.8%
EBITDA · FY 2024
₹16.7 Lakh
EBITDA margin 5.1%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Open charges
₹1.8 Cr
Satisfied ₹45 Lakh
Company age
13 yrs
Est. 2013
Directors on board
3
As per MCA filings

About Medilente Pharma Private Limited

Data last updated:

Medilente Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2013PTC034546. Its GSTIN is 06AAICM6627L1Z2 (Haryana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Pragya Sharma and Rohtas Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.176 Industrial Business Park Phase – 1, Chandigarh, India – 160002.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.24 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹5.99 Lakh (net margin 1.8%) and EBITDA of ₹16.7 Lakh (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 4% over five years.

The company is associated with 1 brand: Medilete Pharma. As per MCA filings, the company has open charges of ₹1.8 Cr and satisfied charges of ₹45 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.

Medilente Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0004600). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medilentepharma.com.

Company details

CIN U24232CH2013PTC034546
Registration Number 034546
Incorporation Date 12 June 2013
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-13-0004600
Key People
Pragya Sharma Director Rohtas Sharma Director Nikhil Sharma Additional Director

Recognitions & Rankings of Medilente Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-HR-13-0004600

Contact details

Medilente Pharma Private Limited's registered office is in Chandigarh, Chandigarh. Its website is medilentepharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    medilentepharma.com
  • Social Media
  • Registered Address
    Plot No.176 Industrial Business Park Phase – 1, Chandigarh, India – 160002
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Medilente Pharma Private Limited, buy the company report.

Comprehensive company report
Medilente Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Medilente Pharma operates one associated brand: Medilete Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Medilete Pharma
Pharmaceutical manufacturing, franchise opportunities, and product supply in India.medilentepharma.com

Business activity

The main business activity of Medilente Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Medilente Pharma Private Limited, buy the company report.

Financials of Medilente Pharma Private Limited

FY 2025 filings available

Medilente Pharma Private Limited reported revenue of ₹3.24 Cr (up 11% YoY) for FY 2024.

Revenue · FY 2024
₹3.24 Cr ▲ 11%
Net profit · FY 2024
₹5.99 Lakh margin 1.8%
EBITDA · FY 2024
₹16.7 Lakh margin 5.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▼ 7%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 30%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 11% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹16.7 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.99 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5.1%
Net Profit Margin1.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medilente Pharma Private Limited, buy the company report.

Board of directors of Medilente Pharma Private Limited

Medilente Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pragya Sharma
Also directs: Healthkynt Labs Private Limited, Healthkind Labs Private Limited
Director12 Jun 201313 Years 4 MonthsCurrent
Rohtas Sharma
Also directs: Healthkynt Labs Private Limited, Healthkind Labs Private Limited, Tanishka Pharmaceuticals Private Limited
Director21 Jan 20233 Years 9 MonthsCurrent
Nikhil Sharma
Also directs: TN International Private Limited
Additional Director23 Apr 20242 Years 6 MonthsCurrent
View all directors

Auditor

Medilente Pharma Private Limited is audited by AMIT K SHARMA & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
AMIT K SHARMA & ASSOCIATESFY 2023021287N

Shareholding

The shareholding of Medilente Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Medilente Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.8 Cr
Satisfied charges
₹45 Lakh
Breakdown by lending institutions
Hdfc Bank Limited₹1.00 Cr
Canara Bank₹0.80 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Dec 2025101203810Hdfc Bank Limited₹1 CrOpen
13 Dec 2024101032524Canara Bank₹80 LakhOpen
16 Jun 2023100780094Hdfc Bank Limited₹45 LakhSatisfied

To see the full charge records of Medilente Pharma Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medilente Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medilente Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
06AAICM6627L1Z2HaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Medilente Pharma Private Limited, buy the company report.

Recent activity

Medilente Pharma Private Limited has 5 board changes on record since 2013: 3 appointments and 2 cessations. The latest: Nikhil Sharma was appointed as Additional Director on 23 Apr 2024.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 101203810 was registered on 11 Dec 2025.
AGM
Medilente Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medilente Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge registered on 16 Jun 2023 via Charge ID 100780094 with Hdfc Bank Limited was fully satisfied on 03 Jan 2025.
Charges
A charge with Canara Bank amounted to Rs. 80.00 Lakh with Charge ID 101032524 was registered on 13 Dec 2024.
Appointed
Nikhil Sharma was appointed as Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 45.00 Lakh with Charge ID 100780094 was registered on 16 Jun 2023.
Appointed
Rohtas Sharma was appointed as Director.
Ceased
Rahul Rawat ceased to be Additional Director.
Ceased
Dharinder Vashishta ceased to be Director.
Appointed
Pragya Sharma was appointed as Director.
Incorporation
12 Jun 2013
Medilente Pharma Private Limited was registered on 12 Jun 2013 with Roc Chandigarh & aged 13 years 4 months as per MCA records.

Frequently asked questions

Medilente Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 2013 (13+ years old) and is registered under CIN U24232CH2013PTC034546.

Medilente Pharma has 3 current directors:

The latest financial statements of Medilente Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Medilente Pharma is 06AAICM6627L1Z2, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Medilente Pharma is U24232CH2013PTC034546. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medilente Pharma has 1 court case on record: 1 filed by the company.

Medilente Pharma was incorporated on 12 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chandigarh.

Nikhil Sharma was appointed as Additional Director on 23 Apr 2024. Rohtas Sharma was appointed as Director on 21 Jan 2023. Rahul Rawat ceased to be Additional Director on 30 Sep 2015. Medilente Pharma has 5 board changes on record in total.

Yes, Medilente Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0004600).

Medilente Pharma can be reached through the website medilentepharma.com. Its registered office is in Chandigarh, India.